ArticleOncotarget2018
The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity.
May Levin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it
ArticleOncotarget2018
May Levin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.